POLYCYSTIC OVARY SYNDROME (PCOS) TREATMENT MARKET ANALYSIS

Polycystic Ovary Syndrome (PCOS) Treatment Market, By Drug Class (Oral contraceptives, Insulin Sensitizing Agents, Anti-Depressants, Ornithine Decarboxylase Inhibitors, Aromatase Inhibitors & SERMs and Diuretics), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Apr 2023
Code : CMI1589
Pages :177
Formats :
Excel and PDF
Industry : Pharmaceutical

Market News

Global Polycystic Ovary Syndrome (PCOS) Treatment Market: Key Developments

Increasing adoption of inorganic growth strategies, such as acquisition and collaboration by key players in the market for the development of novel drug, is expected to n drive the market growth over the forecast period. For instance, in January 2020, Evotec, a biotechnology company, and Bayer AG, a pharmaceutical and biotechnology company, had announced collaboration expansion to develop drug candidates for polycystic ovary syndrome (PCOS).